Literature DB >> 17989117

Validation and comparison of reference equations for the 6-min walk distance test.

C G Cote1, C Casanova, J M Marín, M V Lopez, V Pinto-Plata, M M de Oca, L J Dordelly, H Nekach, B R Celli.   

Abstract

Exercise impairment as measured by the 6-min walk distance (6MWD) test afflicts many patients with chronic obstructive pulmonary disease (COPD) and is known to predict mortality. Reference equations for the 6MWD in adults have been published but not yet validated. The present authors prospectively followed 1,379 COPD patients for 55+/-30 months and tested the predictive value of the baseline 6MWD in metres, the 6MWD work (kg.m(-1)) and as a percentage of predicted values the 6MWD in meters according to two reference equations. All-cause mortality was the validating outcome. The best threshold values were identified for each of the tests using receiver operating characteristic (ROC) curves. The threshold values obtained were: 350 m for the 6MWD, 25,000 kg.m(-1) for the 6MWD work, and 67 and 54% predicted for the two reference equations. All modalities of the testing were similar at predicting COPD mortality and correlated well with the 6MWD test. In conclusion, all modalities of testing predict mortality in chronic obstructive pulmonary disease equally well. In the 6-min walk distance test, a value <350 m is associated with increased mortality and should be regarded as abnormal.

Entities:  

Mesh:

Year:  2007        PMID: 17989117     DOI: 10.1183/09031936.00104507

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  56 in total

1.  Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Authors:  Janelle Yorke; Anne-Marie Russell; Jeff Swigris; Caroline Shuldham; Carol Haigh; Nikki Rochnia; Jennifer Hoyle; Paul W Jones
Journal:  J Asthma       Date:  2011-06-02       Impact factor: 2.515

2.  Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test.

Authors:  J Matt McCrary; David Goldstein; David Wyld; Robert Henderson; Craig R Lewis; Susanna B Park
Journal:  J Cancer Surviv       Date:  2019-06-06       Impact factor: 4.442

3.  The utility of preoperative six-minute-walk distance in lung transplantation.

Authors:  Anthony W Castleberry; Brian R Englum; Laurie D Snyder; Mathias Worni; Asishana A Osho; Brian C Gulack; Scott M Palmer; R Duane Davis; Matthew G Hartwig
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

4.  Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.

Authors:  Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal
Journal:  Ann Am Thorac Soc       Date:  2015-03

5.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

6.  Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD.

Authors:  Alejandro A Diaz; Brian Bartholmai; Raúl San José Estépar; James Ross; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; John J Reilly; Edwin K Silverman; George R Washko
Journal:  Respir Med       Date:  2010-04-10       Impact factor: 3.415

7.  Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial.

Authors:  James A Blumenthal; Patrick J Smith; Michael Durheim; Stephanie Mabe; Charles F Emery; Tereza Martinu; Philip T Diaz; Michael Babyak; Karen Welty-Wolf; Scott Palmer
Journal:  Psychosom Med       Date:  2016 Feb-Mar       Impact factor: 4.312

8.  Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations.

Authors:  A Travassos; A Rodrigues; K C Furlanetto; L Donária; G W Bisca; A G Nellessen; F Pitta; N A Hernandes
Journal:  Eur J Clin Nutr       Date:  2017-07-19       Impact factor: 4.016

Review 9.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

10.  Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.

Authors:  Gian Galeazzo Riario-Sforza; Cristoforo Incorvaia; Fulvia Paterniti; Laura Pessina; Roberta Caligiuri; Chiara Pravettoni; Fabiano Di Marco; Stefano Centanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.